Advertisement
News
Advertisement

Three Mass. biotechs get $1M from myeloma foundation

Fri, 01/07/2011 - 11:36am
Mass High Tech: The Journal of New England Technology

Three Boston-area companies are among 11 biotechnology firms nationwide to receive $1 million research awards from the Multiple Myeloma Research Foundation under the MMRF’s Biotech Investment Awards Program.

Constellation Pharmaceuticals Inc. of Cambridge, Epizyme Inc. of Cambridge and Karyopharm Therapeutics Inc. of Natick were among the 11 companies that received $1 million each for development of treatment of multiple myeloma.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading